1 / 30

CERVIX CANCER EPIDEMIOLOGY IN MOROCCO AND IN THE WORLD

CERVIX CANCER EPIDEMIOLOGY IN MOROCCO AND IN THE WORLD. N. BENJAAFAR; M.A. TAZI; H. ELKACEMI. INTRODUCTION. The second most common cancer in women worldwide:500000/year Cervical cancer is a major public health concern in developing countries: 83% the leading cause of cancer deaths: 85%

Download Presentation

CERVIX CANCER EPIDEMIOLOGY IN MOROCCO AND IN THE WORLD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CERVIX CANCER EPIDEMIOLOGY IN MOROCCO AND IN THE WORLD N. BENJAAFAR; M.A. TAZI; H. ELKACEMI

  2. INTRODUCTION • The second most common cancer in women worldwide:500000/year • Cervical cancer is a major public health concern in developing countries: 83% • the leading cause of cancer deaths: 85% • Second female cancer in Morocco and North Africa • First female cancer in most sub-Saharan countries • Natural history very long, HPV the main cause • screening is efficient • Vaccination?

  3. 633001 inhabitants in 2005 • Rabat Morocco Population Distribution 3

  4. Population Distribution Grand Casablanca 3 615 903

  5. CERVIX CANCER IN MOROCCO • Second female cancer since 1995 in hospital registries and actually in population based • It occurs commonly at younger ages • Most cases are diagnosed at advanced stages • No planned screening for Women at risk

  6. DATA FROM HOSPITAL REGISTRIES • INO: National cancer centre, 35% cases • COIR, Military Hospital, Oujda, Agadir • Alkindy, Littoral, Alazhar, Nakhil • 16000 patients/ year

  7. CERVIXCANCER,INO : % of total number of patients from 2000 to 2006

  8. Evolution of Breast and Cervix cancer at INO : from 1985 to 2006  

  9. Cancer distribution from : 2000 to 2006 female  

  10. Distribution urban/rural

  11. Age • median Age = 50 years • Minimum : 23 years • Maximum : 93 years

  12. Age group distribution

  13. Age group distribution

  14. Pathology • Sc Carcinoma : 90% • Adenocarcinoma : 5% • Sarcoma : 0,5% • Others : 4,5%

  15. Staging 2003 and 2005

  16. Staging 2003 and 2005

  17. Other national hospital registries

  18. DATA FROM POPULATION REGISTRIES • Casablanca, 2004 and Rabat, 2005 • Breast cancer is The leading female cancer and overall: Rabat: ASR: 35.8/100000 33.5% in female Median age: 48 years Casablanca: ASR:35.0/100000 36.1% Median age: 48 years

  19. Data from population registries • Cervix cancer, 2nd female cancer Rabat: ASR:15.4/100000 13.5% Median age: 54 years Casablanca: ASR: 13.5/100000 12.82% Median age: 53.5 years

  20. All anatomical sites Females 20

  21. Principales localisations cancéreuses chez la femme-RCRC 2004. 36,1% Sein Col 12,8% Thyroide 5,3% Ovaires 5% LNH 4% 2,8% Rectum Corps utérin 2,7% Estomac 2,5% 2,3% Peau Colon 2,2% Poumon 1,7% LH 1,6% Vésicule biliaire 1,2% 1,1% Œsophage Autres 16,7%

  22. Data from population registries • Cumulative risk 0-74 years Rabat : 1.9% Casablanca: 1.5% • Pathology Rabat: SCC: 90.2%, Adenocarc: 7.8% Casablanca: SCC: 79%, Adenocarc: 4.7%

  23. Data from population registriesRabat • 93% are invasive, 7% in situ carcinoma • Median age invasive, 54y and in situ, 46y • 12% aged less 40y, Incidence10.7/100000 • The incidence increases with age to a maximum between 65-74years: 90/100000 • 92% were collected from cancer centres • More than 67% are stage II or higher

  24. Uterine cervix cancer, RabatASR:Age group Distribution Age 24

  25. Data from population registriesRabat Staging

  26. Uterine cervix cancer Comparison With other registries 26

  27. CERVIX CANCER IN THE WORLD Age-standardized Incidence and Mortality Rates for Cervix Uteri Cancer. Data shown per 100,000

  28. Cervix cancer in North Africa

  29. CONCLUSION • Cancer du col utérin peut etre évité par un comportement sain et une bonne hygienne • Le dépistage chez les femmes à risque est efficace sur la mortalité et sur l’incidence • Informer la population pour avoir un diagnostic précoce seul garant d’une curabilité

  30. Thank You for your attention 30

More Related